The Journal of Korean Medicine (대한한의학회지)

The Society of Korean Medicine (대한한의학회)
권호 표지
DOI QR코드

DOI QR Code

Development of a Standardized Clinical Pathway in Korean Patients with Gastric Cancer Clinical Application Observational Study

위암 환자의 한의 표준 임상경로(Clinical Pathway) 개발 임상적용 관찰연구

  • Keon-Jun Lee (Department of Oriental Internal Medicine, Pusan National University Korean Medicine Hospital) ;
  • Dong Hyeon Kim (Department of Oriental Internal Medicine, Pusan National University Korean Medicine Hospital) ;
  • Jong-Hee Kim (Department of Korean Medicine, School of Korean Medicine, Daejeon National University ) ;
  • Han-Eum Joo (Department of Korean Medicine, School of Korean Medicine, Daejeon National University) ;
  • Young-Min Cho (Department of Korean Medicine, School of Korean Medicine, Daejeon National University) ;
  • Jung-Hyo Cho (Department of Korean Medicine, School of Korean Medicine, Daejeon National University) ;
  • Ji-Hye Park (Department of Korean Medicine, School of Korean Medicine, Daejeon National University) ;
  • So-Jung Park (Department of Oriental Internal Medicine, Pusan National University Korean Medicine Hospital)
  • 이건준 (부산대학교 한방병원) ;
  • 김동현 (부산대학교 한방병원) ;
  • 김종희 (대전대학교 대전한방병원 한방내과) ;
  • 주한음 (대전대학교 대전한방병원 한방내과) ;
  • 조영민 (대전대학교 대전한방병원 한방내과) ;
  • 조정효 (대전대학교 대전한방병원 한방내과) ;
  • 박지혜 (대전대학교 대전한방병원 한방내과) ;
  • 박소정 (부산대학교 한방병원)
  • Received : 2024.04.19
  • Accepted : 2024.05.07
  • Published : 2024.06.01
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: The objective of this study was to explore the integration of Traditional Korean Medicine (TKM) into existing clinical pathways for the treatment of gastric cancer. focusing on enhancing treatment outcomes and improving patient quality of life. Methods: Employing a prospective observational design, the study targeted adults aged 20-75 diagnosed with gastric cancer. It assessed the TKM pathway's impact on quality of life, tumor markers, complete blood count test values, and patient satisfaction, and monitored adverse reactions to evaluate effectiveness and safety. Results: The study demonstrated improved quality of life(QOL), as indicated by increased Karnofsky Performance Scale(KPS) scores Mean Difference(MD)=20.37, and better quality of life (MD=19.79) assessments. Blood test results showed notable enhancements in immune function markers such as Neutrophil (MD=-7.34%) and Lymphocyte (6.80%), and Erythrocyte Sedimentation Rate (ESR)(MD=-11.05mm/hr). Both patient and medical staff satisfaction (MD=0.33) improved, although changes in tumor markers were not statistically significant. Conclusions: The integration of TKM into the treatment of gastric cancer can significantly improve patient quality of life and satisfaction. To further substantiate these results, developing and implementing more critical pathways across varied clinical settings, along with larger-scaled studies, are essential.

Keywords

Acknowledgement

본 연구는 이 과제는 부산대학교 기본연구지원사업(2년)에 의하여 연구되었음.

References

  1. 2020 Cancer Registry Statistics and 2014-2018 Regional Cancer Incidence Statistics press release. National Cancer Center, 2022. 출처: URL: https://ncc.re.kr 
  2. Yang, Lei, et al. (2020). "Gastric cancer: Epidemiology, risk factors and prevention strategies." Chinese Journal of Cancer Research. 32(6),695. https://doi.org/10.21147/j.issn.1000-9604.2020.06.03 
  3. Kang, Mee Joo, et al. (2023). "Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2020." Cancer Research and Treatment. Official Journal of Korean Cancer Association. 55(2), 385. https://doi.org/10.4143/crt.2023.447 
  4. Park SH, Lee SI. (2012). Recent Advances in Chemotherapy of Gastric Cancer. The Korean Journal of Medicine, 82(4), 417-26. DOI: https://doi.org/10.3904/kjm.2012.82.4.417 
  5. 설은미. (2021). 위암 수술 환자의 건강관련 삶의 질 구조모형. Doctoral dissertation, 서울대학교 대학원. 
  6. Zhao P, Lei XM, (2013). Progress in causes of cancer-related fatigue[J]. Journal of Modern Oncology, 21(4), 894-898. https://doi.org/10.3969/j.issn.1672-4992.2013.04.77 
  7. Oh IO, Chang TI, Kim HJ, (2022). Status of the Development and Utilization of Critical Pathways. Quality Improvement in Health Care, 28(1), 2-13. DOI: https://doi.org/10.14371/QIH.2022.28.1.2 
  8. Chang SB, Lee TW, Kim S. (2006). A study of complementary and alternative medicine used by cancer patients in Korea. J Korean Acad Adult Nurs, 92-101. 
  9. Hwang CY, (1997). Bibliographic Study on the Therapy of Gastric Cancer by Intergrated Oriental and Western Medicine. The Journal of Wonkwang Oriental Medicine, 7(1):10-8. 
  10. Jung JH, Seo JC, Kwak MA, Sohn KC. (2014). Literature Review on Traditional Chinese Medicine Treatment of Gastric Cancer. J Int Korean Med, 35(3), 332-42 
  11. Konishi T, Noye T, Furujima K, Harihara Y. (2001). Significance of critical path for gastric cancer: Gastrointestinal diseases and social medicine. Nippon Shokakibyo Gakkai Zasshi; 98(12), 1341-8 
  12. Hong MN, Shim SH, Yoon SH. (2017), Development and Validity Test on Preliminary Critical Pathway of Integrative Medicine for Lung Cancer Patients Treated with Chemotherapy. J Int Korean Med, 38(6), 917-29. https://doi.org/10.22246/jikm.2017.38.6.917 
  13. 김기연. (1996). 관상동맥 우회술 환자를 위한 Critical pathway 개발. 연세대학교 대학원 간호학과 석사논문, 28(1), 117-131. 
  14. 김효린, et al. (2016). 위암 치료에 대한 한의 임상 가이드라인. 대한한방내과학회지 제 37(1). 
  15. Park SJ, Yoo HS, Cho CK, et al. (2023). The Korean Association of Traditional Oncology. Clinical Practice Guideline of Korean Medicine for Gastric Cancer Panmuneducation. National Institute for Korean Medicine Development, 1-177 
  16. Kwon HK, Kim JS, Yu HS. (2009). Review for the Status of Cancer Complementary and Alternative Medicine in the World. J Korean Tradit Oncol, 14(1), 1-11. 
  17. Kim MH, Kang PS, Lee KS. (2007). Utilization of Complementary and Alternative Medicine of Cancer Patient in Korea. J Agr Med Community Health, 32(3), 155-67. 
  18. Yoo SH, Yoo HS, Cho CK, Lee YW. (2007). A Case Report for Recurred Squeamous Cell Lung Carcinoma Treated with Hang-An-Dan: 7-year follow-up. Korean J Int Korean Med, 28(2), 385-90. 
  19. Choi JY, Lee JY, Kim ES, et al. (2008). Clinical data analysis of 106 breast cancer patients who received oriental medical treatment. The Journal of Korean Obstetrics and Gynecology, 21(4), 228-236. 
  20. 고금영, 박소정, et al. (2023), '표준치료를 받은 폐암 환자의 한방병원 입원 임상경로'개발 및 적용. J Physiol & Pathol Korean Med, 37(6), 178~184. http://dx.doi.org/10.15188/kjopp.2023.12.37.6.178 
  21. 송교영, 김승남, and 박조현. (2005). 위암수술 환자에서의 critical pathway의 개발과 적용. 대한위암학회지, 5(2), 95-100.